Cargando…

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C

BACKGROUND: Entecavir (ETV) is a potent and selective nucleotide analog with significant activity against hepatitis B virus (HBV). ETV maleate is a derivative compound of ETV and was reported to have an efficacy and safety profile that is comparable to ETV (Baraclude) when used in Chinese patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jing-Hang, Wang, Sa, Zhang, Da-Zhi, Yu, Yan-Yan, Si, Chong-Wen, Zeng, Zheng, Xu, Zhong-Nan, Li, Jun, Mao, Qing, Tang, Hong, Sheng, Ji-Fang, Chen, Xin-Yue, Ning, Qin, Shi, Guang-Feng, Xie, Qing, Zhang, Xi-Quan, Dai, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Clinical Trials Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561570/ https://www.ncbi.nlm.nih.gov/pubmed/36246814 http://dx.doi.org/10.12998/wjcc.v10.i28.10085

Ejemplares similares

240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C
por: Xu, Jing‐Hang, et al.
Publicado: (2022)

Hundred and ninety first Session of the Council
por: Ordan, Julien, et al.
Publicado: (2018)

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks
por: Chen, Xiao-Fan, et al.
Publicado: (2021)

Draft Minutes of the Two-hundred-and-ninety-eighth Meeting
Publicado: (2016)

Council Restricted Session - Hundred-and-Ninety-Second Session of Council
por: Ordan, Julien, et al.
Publicado: (2019)

Approval of the Draft Minutes of the Two-hundred-and-ninety-ninth Meeting
Publicado: (2016)

Agenda for the hundred-and-ninety-first Meeting of the CERN Research Board
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2010)

Approval of the Draft Minutes of the Two-hundred-and-ninety-seventh Meeting
Publicado: (2016)

Approval of the Draft Minutes of the Two-hundred-and-ninety-sixth Meeting
Publicado: (2016)

Approval of the Draft Minutes of the Hundred-and-Ninety-Third Session - Restricted Council
Publicado: (2019)

Approval of the draft minutes of the hundred-and-ninety-fourth Session - Restricted Council
Publicado: (2019)

Approval of the draft minutes of the Hundred-and-Ninety-Ninth Session - Restricted Council
Publicado: (2020)

Agenda of the Two-hundred-and-ninety-fourth Meeting - 19 March 2003
Publicado: (2003)

Approval of the Draft Minutes of the Hundred-and-Ninety-First Session of Council – Restricted Session
Publicado: (2019)

Approval of the Draft Minutes of the Hundred-and-Ninety-Second Session of Council - Restricted Session
Publicado: (2019)

DRAFT AGENDA of the Two-hundred-and-ninety-fifth Meeting - 5 June 2003
Publicado: (2003)

Draft Agenda of the Two-hundred-and-ninety-seventh Meeting - 17 September 2003
Publicado: (2003)

Draft Agenda of the Two-hundred and ninety-first Meeting - 18 September 2002
por: European Organization for Nuclear Research
Publicado: (2002)

Draft Agenda of the Two-hundred-and-ninety-second Meeting - 6 November 2002
Publicado: (2002)

Draft Agenda of the Two-hundred-and-ninety-third Meeting - 11 December 2002
Publicado: (2002)

Evaluation of Male Circumcision: Retrospective Analysis of One Hundred and Ninety-eight Patients
por: Ferhatoglu, Murat F, et al.
Publicado: (2019)

Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
por: Wei, Lai, et al.
Publicado: (2018)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
por: Ahn, Sang Hoon, et al.
Publicado: (2013)

Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)

Effect of individualized weight management intervention on excessive gestational weight gain and perinatal outcomes: a randomized controlled trial
por: Xu, Mei-Yan, et al.
Publicado: (2022)

Descriptive study of management of palatal fistula in one hundred and ninety-four cleft individuals
por: Murthy, Jyotsna
Publicado: (2011)

Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B
por: Cao, Lihua, et al.
Publicado: (2023)

Approval of the Draft Minutes of the hundred-and-ninety-third Session on 21 June 2019 – Open Council
Publicado: (2019)

Agenda for the hundred-and-ninety-fourth Meeting of the CERN Research Board - Wednesday, 1 December 2010
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2010)

Agenda for the hundred-and-ninety-fifth Meeting of the CERN Research Board - Wednesday, 2 March 2011
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2011)

Agenda for the hundred-and-ninety-sixth Meeting of the CERN Research Board - Wednesday, 8 June 2011
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2011)

Agenda for the hundred-and-ninety-seventh Meeting of the CERN Research Board - Wednesday, 31 August 201
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2011)

Agenda for the hundred-and-ninety-eighth Meeting of the CERN Research Board - Wednesday, 30 November 2011
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2011)

Agenda for the hundred-and-ninety-ninth Meeting of the CERN Research Board - Wednesday,29 February 2012
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2012)

Agenda for the hundred-and-ninety-third Meeting of the CERN Research Board - Wednesday 8 September 2010
por: CERN. Geneva. Research Board Committee, et al.
Publicado: (2010)

Approval of the draft minutes of the hundred-and-ninety-sixth Session on 13 December 2019 – Open Council
Publicado: (2020)

Approval of the draft minutes of the hundred-and-ninety-ninth Session on 19 June 2020 – Open Council
Publicado: (2020)

Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
por: Yu, Jiao, et al.
Publicado: (2022)

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
por: Gui, Hong-Lian, et al.
Publicado: (2020)

Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
por: Liu, Zhihong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69hmmugq9s70tm7m6l0usmb0jn